Clinical Trial Update: Measuring Sensitivity to Nonignorability

View source ↗

Summary

NHLBI-sponsored clinical trial update reporting a completed study on measuring sensitivity to nonignorability in cardiovascular research.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Heart Disease

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Cardiovascular Diseases, Heart Diseases | Status: COMPLETED